Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers

IMPORTANCE: Prophylactic bilateral salpingo-oophorectomy is recommended for BRCA1 mutation carriers to prevent ovarian cancer. Whether or not hormone replacement therapy (HRT) initiated after oophorectomy is associated with an increased risk of breast cancer has not been evaluated in a prospective s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA Oncol
Prif Awduron: Kotsopoulos, Joanne, Gronwald, Jacek, Karlan, Beth Y., Huzarski, Tomasz, Tung, Nadine, Moller, Pal, Armel, Susan, Lynch, Henry T., Senter, Leigha, Eisen, Andrea, Singer, Christian F., Foulkes, William D., Jacobson, Michelle R., Sun, Ping, Lubinski, Jan, Narod, Steven A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2018
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143051/
https://ncbi.nlm.nih.gov/pubmed/29710224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.0211
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg